beta hydroxyethylrutoside
PolandDrugs containing this active substance
-
The medicinal product is used for the symptomatic treatment of chronic venous insufficiency (varicose veins of the lower legs), which helps to reduce swelling and relieve symptoms such as pain, muscle cramps, a feeling of heaviness in the legs, burning, or tingling. It is also used in the treatment of hemorrhoids and as an adjunct in microangiopathies associated with diabetes.
Form: tablets
Active substance Dosage beta hydroxyethylrutoside 500 mg ATC: C05CA04
Manufacturer: GlaxoSmithKline Consumer Healthcare GmbH & Co. KG Recipharm Uppsala AB STADA Arzneimittel AG